According to current analysis of Reports and Data, the global Home Infusion Therapy Market was valued at USD 18.21 Billion in 2020 and is expected to reach USD 44.63 Billion by the year 2028, at a CAGR of 8.30%. Infusion therapy involves the administration of drugs intravenously. It is prescribed when a patient’s condition is much severe and cannot be treated effectively by oral medications. Receiving this therapy in homecare settings rather than hospitals is referred to as home infusion therapy. Home infusion therapies are very cost-effective, and technological advancements have facilitated safe and effective administration of infusion therapies at home. The advantage infusion offers is that it helps deliver a precise dose of the drug quickly and efficiently, and in a well-controlled manner throughout the body. It is also used for irritating solutions; those can cause pain and even damage tissues if administered by subcutaneous or intramuscular injection.
Moving care into the home is a very important step of change in healthcare. The approach is patient-centric. Home infusion therapy let patients reduce or even totally avoid outpatient hospital visits, and allows them to resume normal routines and work behaviors while still treating their illness. Home infusion therapy works closely with the patient to ensure that such services are appropriate and in the interest of the best patient care. Moreover, the outcome of home infusion therapy is reliable. Favorable government policies and regulations, increasing geriatric population, rapid technological developments, and increasing adoption of home infusion therapies, are some of the key factors propelling market growth in the industry. High prevalence of chronic diseases such as HIV, cancer, diabetes is further expected to fuel market growth. Home infusion drugs are often not readily available through standard pharmacies and comparatively higher in cost. Most are obtained through hospital pharmacies, licensed home infusion agencies, or mail-order discount drug supply companies that can express deliver the drugs directly to the patient's home. However, increasing risk with patient's safety and occurrence of mistakes while using infusion devices and issues related to reimbursement policies for home infusion therapy are the major hindrance for market growth during the forecast period.
Request a sample Report of the Home Infusion Therapy Market @ https://www.reportsanddata.com/download-free-sample/2250
Further key findings from the report suggest
- Home Infusion Therapy is growing at a CAGR of 3% in Asia Pacific followed by North America and Europe, with 7.2 % and 6.9% CAGR, respectively. High incidence of chronic diseases and availability of cost-effective home infusion therapies in developing and developed economies are expected to accelerate the market growth for home infusion therapy during forecast period across all regions
- As of 2018, Anti-infective application segment is expected to dominate Home infusion therapy which holds the market share of 33.9% of the global market. North America region is the chief revenue generating source for this product segment, followed by Europe and Asia-Pacific regions
- Chemotherapy is expected to be the fastest growing market segment during forecast period 2019-2026 with a CAGR of 7.7%. It is also the second largest segment in terms of revenue generation after anti-infective segment. For instance, according to the data of cancer organization, by January 1 2030, it is estimated that the population of cancer survivors will increase to more than 22.1 million due to the growth and aging of the population alone
- Infusion pumps segment led the global infusion therapy market with a market share of 34.7% in 2018 and is forecasted to continue its dominance during the forecast period. Extensive application in delivering fluids containing nutrients and medications in controlled dosages is anticipated to fuel market growth
- Needleless connectors segment is anticipated to witness lucrative growth with a CAGR of 7.9% registering fastest growth during the forecast period.
- Key players in the home infusion therapy industry are taking initiatives to educate and promote home infusion therapy among the patients by providing educational tools and apps that can be utilized for infusion therapies. For instance, in October 2018, Baxter International Inc. in collaboration with American Society for Parenteral and Enteral Nutrition (ASPEN) launched SmartPN tool to help reduce clinical malnutrition.
- Asia Pacific is expected to account for the 21.1% of the global Home Infusion Therapy. Developing nations such China, and India are likely to witness high growth
- North America region accounts for the largest market share of 37.6% followed by Europe
Inquiry Before Buying @ https://www.reportsanddata.com/inquiry-before-buying/2250
Key Players covered in this report are:
Baxter, B. Braun Melsungen AG, ICU Medical Inc., Fresenius Kabi AG, Terumo Corporation, JMS Co. Ltd., CareFusion Corporation, Smiths Medical and Caesarea Medical Electronics.
Product (Revenue, USD Million; 2018–2028)
- Infusion pumps
- Intravenous sets
- IV Cannulas
- Needleless connectors
Application (Revenue, USD Million; 2018–2028)
- Anti-infective
- Endocrinology
- Hydration therapy
- Chemotherapy
- Enteral nutrition
- Parenteral nutrition
- Special pharmaceuticals
Based on Region market is segmented into:
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Major Points covered in this report are as below:
- The Home Infusion Therapy industry development trends and marketing channels are analyzed. The feasibility of new investment projects are assessed and overall research conclusions offered.
- Home Infusion Therapy industry development trends, marketing channels, feasibility of new investment projects, and overall conclusions of research are presented.
With the tables and figures, the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
As a valuable source of guidance and direction for companies and individuals interested in the market, the report provides key statistics on the state of the industry through tables and figures. - Development policies and plans, manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand figures, cost, price, revenue and gross margins.
- This report also analyzes production processes, production costs and import/export figures, as well as cost, price, revenue and gross margins, as well as development policies
- The Home Infusion Therapy Market report provides key statistics on the market status of the Home Infusion Therapy manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.
As well as providing key statistics on the market status of the Home Infusion Therapy manufacturers, the Home Infusion Therapy Market report provides valuable guidance and direction for companies and individuals interested in the industry.
We can also provide the customized data for separate regions like North America, United States, Canada, Mexico, Asia-Pacific, China, India, Japan, South Korea, Australia, Indonesia, Singapore, Rest of Asia-Pacific, Europe, Germany, France, UK, Italy, Spain, Russia, Rest of Europe, Central & South America, Brazil, Argentina, Rest of South America, Middle East & Africa, Saudi Arabia, Turkey, Rest of Middle East & Africa
Ask For customization of Report @ https://www.reportsanddata.com/request-customization-form/2250
This study aims to define market sizes and forecast the values for different segments and countries in the coming eight years. The study aims to include qualitative and quantitative perspectives about the industry within the regions and countries covered in the report. The report also outlines the significant factors, such as driving factors and challenges, that will determine the market’s future growth.
Explore More Industry Research by Reports and Data:
Ambulatory Surgery Center (ASC) Market @ https://www.biospace.com/article/ambulatory-surgery-center-asc-market-growth-2028-growing-aging-population-rising-healthcare-costs-and-technological-advances/
Tinnitus Management Market @ https://www.biospace.com/article/tinnitus-management-market-demand-analysis-by-2030-increasing-geriatric-population-is-a-major-factor-driving-industry-revenue-growth/
Interstitial Cystitis Market @ https://www.biospace.com/article/interstitial-cystitis-market-growth-by-2030-increasing-prevalence-of-autoimmune-diseases-and-rising-women-population-across-the-globe-is-a-major-factor-driving-industry-revenue-growth/
Panic Disorder Market @ https://www.biospace.com/article/panic-disorder-market-growth-analysis-by-2030-increase-in-the-number-of-people-being-diagnosed-with-panic-disorder-particularly-as-a-result-of-increasing-mental-issues/
Traumatic Brain Injury Treatment Market @ https://www.biospace.com/article/north-america-dominated-the-traumatic-brain-injury-treatment-market-and-is-again-expected-to-grow-throughout-the-projected-period-2022-2030/
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, TouchPoints, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provide our clients with the ability to secure an edge over their respective competitors.
Contact Us:
John W
Head of Business Development
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
0 Comments
Post a Comment